GIM
FBRX icon

Granahan Investment Management’s Forte Biosciences FBRX Stock Holding History

Granahan Investment Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-105
Closed -$264K – 181
2019
Q2 		$264K Sell
105
-1
-0.9% -$2.96K 0.01% 181
2019
Q1 		$431K Sell
106
-5
-5% -$19.3K 0.02% 185
2018
Q4 		$342K Sell
111
-2
-2% -$8.61K 0.02% 182
2018
Q3 		$662K Hold
113
– – 0.04% 185
2018
Q2 		$396K Buy
113
+15
+15% +$54.9K 0.02% 192
2018
Q1 		$434K Buy
98
+2
+2% +$9.26K 0.03% 189
2017
Q4 		$370K Buy
96
+12
+14% +$47.9K 0.03% 193
2017
Q3 		$392K Buy
+84
New +$374K 0.03% 184

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Granahan Investment Management's FBRX Position: Q3 2019 in Review

Granahan Investment Management sold out of Forte Biosciences (FBRX) in Q3 2019, closing a stake of 105 shares — an estimated $264K sold.

Granahan Investment Management first reported a position in FBRX in Q3 2017 and held it in 8 quarters. The position peaked at $662K in Q3 2018. 58 funds tracked by Wall St. Rank hold FBRX as of Q3 2019.

  • Granahan Investment Management reported no remaining Forte Biosciences position as of Q3 2019 after selling out during the quarter.
  • Granahan Investment Management sold 105 Forte Biosciences shares in Q3 2019, an estimated $264K.
  • Granahan Investment Management first reported a position in Forte Biosciences in Q3 2017 and held it in 8 quarters.
  • Granahan Investment Management's Forte Biosciences position peaked at $662K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2019.

Based on Granahan Investment Management's 13F filing for Q3 2019, filed 15 Nov 2019.